pfizer
Pfizer wins over Novo to acquire obesity start-up Metsera
Pfizer won the bidding war against Novo Nordisk to acquire Metsera, a biotech specializing in obesity drugs. The pharmaceutical giant increased its offer, valuing the startup at around $10 billion, Metsera announced Friday. In a statement, the biotech also said it received a call from the Federal Trade Commission regarding the potential risks of Novo’s […]
4 mins read
A tragic paradox, Gilead updates and a lot of new pfizer
Adam Feuerstein / Stat Matthew Herper covers medical innovation – both his promise and his perils. Adam Feuerstein is a main writer and biotechnology columnist, reporting on the crossroads of drug development, business, Wall Street and biotechnology. He is also co-host of the weekly biotech podcast The Readout Loud and author of the Biotech dashboard […]
3 mins read